| abstract |
The present invention relates to antibodies or antigen-binding fragments thereof that specifically bind to an epitope of a sclerostin peptide and are capable of increasing bone density or mineral content in a mammalian bone. An increase in bone mineral density is useful in diseases and conditions in which low bone mineral density is characterized for a condition such as osteopenia, osteoporosis - bone fractures. |